E-Books durchsuchen
Frontiers in Clinical Drug Research - Alzheimer Disorders [2013]
- 1
-
Immunotherapy with Anti-Aβ Monoclonal Antibodies in Alzheimer’s Disease: A Critical Review on the Molecules in the Pipelines with Regulatory Considerations
- 2
-
The Development of Multi-Target-Directed Ligands (MTDL) to Treat Alzheimer’s Disease
- 3
-
Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside
- 4
-
Tau-Directed Therapies for Alzheimer’s Disease and Other Tauopathies
- 5
-
Different Approaches in the Treatment of Alzheimer's Disease: Comprehensive Insight
- 6
-
Alzheimer’s Disease and Dementia: A Midlife Approach to Treatment is Needed
- 7
-
Neurogenic Molecules Modulating Cell Survival Pathways, Amyloid Beta, Tau Proteins, and Metal Dyshomeostasis: An Alternative Hope for Alzheimer’s Therapy
- 8
-
Cognitive Decline and Alzheimer's Disease: A Central Role for Hypoxia-Obstructive Sleep Apnea and Related Stigmata in Elderly
- 9
-
Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs
- 10
-
Challenges in the Morphological Diagnosis of Dementias
- 11
-
Metal Ions in the Pathogenesis of Alzheimer’s Disease: An Open Field
- 12
-
Index